Loading…
Based on limited metadata, this FDA Warning Letter issued to Phase 4 Pharmaceutical LLC on April 18, 2018, concerns a pharmaceutical company but lacks specific details about the violation nature or issuing office. Without access to the full letter text or subject line, the precise regulatory concerns cannot be determined from the available information. This warning likely indicates FDA compliance issues requiring corrective action, though the specific product category and violation details remain unclear from the metadata provided.